-
Plant Virus Movement Protein Phase Separation
2026-09-07
Brown, Garrison, and May show that the Pea enation mosaic virus 2 movement protein p26 uses charge-dependent phase separation to associate with both proviral fibrillarin and antiviral G3BP compartments. Mutational, biochemical, and plant infection assays connect condensate partitioning with nucleolar trafficking, systemic movement, and restriction of viral RNA accumulation.
-
Cytosolic DNA and TDP-43 Homeostasis in Neurodegeneration
2026-09-07
A 2024 Journal of Biological Chemistry study identifies cytosolic DNA accumulation as a trigger of TDP-43 condensate formation, nuclear depletion, and short-isoform production. Its experiments connect DNA uptake, DNA damage, and impaired nuclear-envelope integrity with mechanisms relevant to TDP-43 proteinopathy in ALS and related neurodegenerative disease.
-
Sulforaphane, ROS, and NLRP3 in Experimental Colitis
2026-09-05
A 2024 study in Biomedicine & Pharmacotherapy links sulforaphane-mediated reduction of reactive oxygen species with suppression of NLRP3 inflammasome signaling in dextran sulfate sodium-induced mouse colitis. Its combined animal and RAW264.7 macrophage experiments provide a useful mechanistic framework for studying redox-sensitive inflammation while underscoring the limits of translating preclinical findings to human ulcerative colitis.
-
Rotigotine: Dopamine D2/D3 Agonist Workflows
2026-09-05
Rotigotine is a versatile dopamine D2/D3 receptor agonist for connecting receptor pharmacology with cellular neuroprotection and behavioral phenotyping. This workflow-focused guide translates antidepressant-model findings into practical Parkinson’s disease research, assay design, dosing, and troubleshooting decisions.
-
FPS-ZM1: A RAGE Inhibitor for Mechanistic Assays
2026-09-04
FPS-ZM1 enables receptor-focused studies of amyloid beta transport, cellular stress, and neuroinflammation while offering a practical way to test emerging RAGE/POMC biology. This workflow separates product-supported evidence from assay recommendations for Alzheimer’s disease research and metabolic neuroscience.
-
Mycobacterium tuberculosis WecA: Kinetic Study
2026-09-04
The reference study establishes a practical route for producing and functionally analyzing the difficult membrane enzyme WecA from Mycobacterium tuberculosis. Its controlled expression strategy, mass-spectrometric identity confirmation, UMP-based activity assay, and competitive inhibition analysis provide a useful platform for mechanistic research and WecA-directed anti-tuberculosis drug discovery.
-
Reelin Signaling Enables Ketamine Synaptic Action
2026-09-03
This PNAS study identifies Reelin–Apoer2–Src family kinase signaling as a permissive pathway for ketamine-induced hippocampal synaptic plasticity and behavioral effects. Its genetic, pharmacological, and electrophysiological evidence suggests that preserved baseline NMDA receptor function may help determine responsiveness to ketamine.
-
Leucomycin: Component-Aware Assay Design
2026-09-02
Leucomycin (kitasamycin) is best interpreted as a biologically active macrolide complex rather than a single uniform molecule. This guide explains how component composition, ribosomal mechanism, solvent handling, and resistance genetics should shape translational inhibition studies and bacterial growth inhibition assays.
-
Carcinogen-Induced seRNA Drives NPC Metastasis
2026-09-02
The 2023 reference study identifies seRNA-NPCm as a carcinogen-responsive super-enhancer RNA that promotes nasopharyngeal carcinoma metastasis through an NPM1/c-Myc/NDRG1 regulatory axis. Its integrated sequencing, chromatin, functional, and patient-sample analyses provide a mechanistic framework for connecting chemical exposure with enhancer activation and metastatic behavior.
-
DAT Neuroimaging Tracks Dopamine Neuron Maturation
2026-09-02
Goggi et al. showed that longitudinal dopamine transporter PET can assess the survival, maturation, and presynaptic restoration of transplanted human embryonic stem cell-derived dopaminergic neurons in a rat model of Parkinson’s disease. The study also demonstrates why DAT imaging should be interpreted alongside functional dopamine-release measures, behavior, and endpoint histology rather than treated as a standalone measure of graft performance.
-
Sulforaphane, ROS, and NLRP3 in Ulcerative Colitis
2026-09-01
A 2024 study in Biomedicine & Pharmacotherapy shows that sulforaphane reduces dextran sodium sulfate-induced colitis in mice while suppressing oxidative stress and NLRP3 inflammasome signaling. The work connects reactive oxygen species with inflammatory cytokine release and provides a useful framework for mechanistic inflammation studies, while remaining preclinical.
-
Amt-1 Activates Nrf2/HO-1 Against Influenza A
2026-08-31
The reference study identifies Amt-1, an adamantane-2,5-dihydroxy-benzylalcohol derivative, as a dual-action influenza A virus inhibitor that combines residual M2 ion-channel interaction with Nrf2/HO-1-mediated control of inflammation. Its activity in cell and mouse models suggests a host-directed strategy for addressing antiviral resistance and virus-induced lung injury, although additional pharmacological and translational studies are needed.
-
Separating Growth Arrest from Cell Killing in Cancer Assays
2026-08-31
Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a response-analysis framework that distinguishes proliferative arrest from true cell killing, improving interpretation of in vitro drug studies and informing more rigorous assay design.
-
EdU Imaging Kits (488) in CRC Translation
2026-08-30
A mechanistic and translational perspective on using EdU-based S-phase DNA synthesis measurement to strengthen colorectal cancer research, including studies of the EIF4A3–circEIF2S2–miR-646–UHMK1 axis.
-
Ampicillin sodium for Reliable Assay Workflows
2026-08-29
Learn how Ampicillin sodium (SKU A2510) can support controlled antibacterial activity assays while preventing antibiotic-related confounding in cell viability, proliferation, and cytotoxicity workflows. The article connects mechanism, protocol parameters, resistance interpretation, and practical product-selection criteria to improve experimental comparability.